It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human T cells coordinate adaptive immunity in diverse anatomic compartments through production of cytokines and effector molecules, but it is unclear how tissue site influences T cell persistence and function. Here, we use single cell RNA-sequencing (scRNA-seq) to define the heterogeneity of human T cells isolated from lungs, lymph nodes, bone marrow and blood, and their functional responses following stimulation. Through analysis of >50,000 resting and activated T cells, we reveal tissue T cell signatures in mucosal and lymphoid sites, and lineage-specific activation states across all sites including distinct effector states for CD8+ T cells and an interferon-response state for CD4+ T cells. Comparing scRNA-seq profiles of tumor-associated T cells to our dataset reveals predominant activated CD8+ compared to CD4+ T cell states within multiple tumor types. Our results therefore establish a high dimensional reference map of human T cell activation in health for analyzing T cells in disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA
2 Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA
3 Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA
4 Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA
5 Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA
6 Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY, USA